EARNINGS
RELEASE
4Q
2024
Contact ir.rededor.com.br ri@rededor.com.br
ABOUT THIS
REPORT
Rede D'Or São Luiz ("Rede D'Or") presents its results for the fourth quarter and the year of 2024 based on managerial analyses that the administrators believe best interpret the
Company's business, reconciled with the international Financial Statement reporting standards.
For further information, we recommend reading the Financial Statements of December 31, 2024, available on the Rede D'Or's Investor Relations website: http://www.rededor.com.br/ir.
In this document, the term SulAmérica is used to address the insurance and pension operations.
DISCLAIMER: SULAMÉRICA ACCOUNTING AND IFRS 17 ADOPTION
Due to the merger of Sul América S.A. ("SulAmérica") being completed on December 23, 2022, the Financial Statements of Rede D'Or São Luiz S.A. ("Rede D'Or") did not include the income statement balances for the 2022 fiscal year of SulAmérica. From the Financial Statements of Rede D'Or on March 31, 2023, SulAmérica's results are fully included in the Income Statement, as well as the Accounting Cash Flow and Balance Sheet.
In preparing this report, Rede D'Or chose to present selected operational and financial indicators for Rede D'Or and SulAmérica separately, on a voluntary, managerial, and unaudited basis.
The Company also reinforces the disclaimer available on the previous page, in the context of any declarations that may be made related to the combination between Rede D'Or and SulAmérica. For further information regarding the risks that should be considered, please see section 4, "Risk Factors", of Rede D'Or's Reference Form, available on the Company's IR website, as well as the files directory of Rede D'Or on the CVM website.
The adoption of IFRS 17/CPC 50 for insurance contracts, which impacts SulAmérica's operations, introduced changes to accounting practices and the way the Company's financial statements are released.
For the purposes of managerial analysis and better comparability between periods, the results presented in this document continue to consider IFRS 4/CPC 11, the previous accounting standard. For the reconciliation of the financial information in accordance with the IFRS 17/CPC 50 standard, see the annexes of this report, starting on page 34.
www.ri.rededorwww.ri.rededor.com.br.com.br | Earnings Release 4Q24 | 2 |
www.ri.rededor.com.br |
ABOUT US
Rede D'Or ("Company"), the largest private
healthcare network in the country, in existence for 47 years, is present in 13 states (Rio de Janeiro, São Paulo, Pernambuco, Bahia, Maranhão, Sergipe, Ceará, Paraná, Minas Gerais, Mato Grosso do Sul, Paraíba, Alagoas, and Pará) and the Federal District.
On December 23, 2022, Rede D'Or value proposition was significantly enhanced with the consummation of the merger with SulAmérica - one of Brazil's leading independent insurers.
With operations in the health, dental, life and personal accident insurance segments, in addition to asset management and private pension products, SulAmérica had more than 7 million customers distributed throughout Brazil on December 31, 2024.
On August 16, 2024, after receiving the necessary regulatory approvals, Rede D'Or established a new network of hospitals (Atlântica D'Or) in partnership with Bradesco Seguros, aiming to strengthen its expansion potential and ensuring greater alignment with one of its most important commercial partners.
On December 31, 2024, the Company operated 78 hospitals, of which 75 are owned and 3 are under management,
totaling 13,054 beds and the country's
largest integrated cancer treatment network. In addition, Rede D'Or has one of the largest diagnostic networks in Brazil; an extensive blood bank operation; one of the largest health consultancies in the country; and the largest and most advanced robotic surgery park in Latin America.
www.ri.rededorwww.ri.rededor.com.br.com.br | Earnings Release 4Q24 | 3 |
www.ri.rededor.com.br |
INDEX
HIGHLIGHTS AND PL . . . . . . . 05
01 HIGHLIGHTS AND P&L . . . . . . . 05
ESG AND DIGITAL . . . . . . . . . 09
02 ESG AND DIGITAL . . . . . . . . . 09
GROWTH . . . . . . . . . . . . . . . . 13
03 GROWTH . . . . . . . . . . . . . . . . 13
OPERATIONAL . . . . . . . . . . . . 15
04 OPERATIONAL . . . . . . . . . . . . 15
REVENUES . . . . . . . . . . . . . . . 18
05 REVENUES . . . . . . . . . . . . . . . 18
COSTS . . . . . . . . . . . . . . . . . . 20
06 COSTS . . . . . . . . . . . . . . . . . . 20
EXPENSES . . . . . . . . . . . . . . . 21
07 EXPENSES . . . . . . . . . . . . . . . 21
EBITDA . . . . . . . . . . . . . . . . . .23
08 EBITDA . . . . . . . . . . . . . . . . . .23
SULAMÉRICA . . . . . . . . . . . . . 24
09 SULAMÉRICA . . . . . . . . . . . . . 24
FINANCIAL RESULT . . . . . . . . . 27
10 FINANCIAL RESULT . . . . . . . . . 27
NET INCOME . . . . . . . . . . . . . 27
11 NET INCOME . . . . . . . . . . . . . 27
DEBT . . . . . . . . . . . . . . . . . . . 29
12 DEBT . . . . . . . . . . . . . . . . . . . 29
CASH FLOW . . . . . . . . . . . . . . 32
13 CASH FLOW . . . . . . . . . . . . . . 32
PERFORMANCE APPENDIX . . . 33
14 PERFORMANCE & APPENDIX . . . 33
www.ri.rededorwww.ri.rededor.com.br.com.br | Earnings Release 4Q24 | 4 |
www.ri.rededor.com.br |
HIGHLIGHTS
REDE D'OR
- Inauguration of five new hospitals throughout the year, including the first Atlântica D'Or units in partnership with Bradesco Seguros.
- Bed occupancy rate reaches 79.6% in
2024, surpassing the Company's historical record. - Gross revenue exceeds the thirty billion mark in the year for the first time, totaling R$31.3 billion in revenue (+10.1% vs. 2023).
- Oncology increases 16.8% YoY in gross revenue, driven by a 11.9% increase in the average ticket of the segment and a 4.4% expansion in the volume of infusions.
- Annual average ticket advances 6.8% in 2024.
- EBITDA totals R$7.2 billion in 2024, expansion of 12.9% vs. 2023, with 25.8% margin.
SULAMÉRICA
- SulAmérica's net revenue surpasses R$30.0 billion in the year, increase of 11.3% YoY, reflecting portfolio price adjustments and expansion of the membership base.
- Consolidated loss ratio of 82.0% in 2024 improvement of 4.4 pp vs. 2023 and 6.5 pp vs. 2022.
- Health and dental portfolio increase 7.5% YoY and exceeds 5.3 million beneficiaries.
- Level of administrative expenses (disregarding provisions for contingencies) in relation to revenues of 4.6% in 2024 (4.8% in the previous year and 6.9% in 9M22 pre-incorporation).
- EBITDA amounts R$1.3 billion in the year, after recording just R$12.9 million in 2023. Adjusted EBITDA by financial results over restricted assets totaled R$2.3 billion in 2024, expanding 131.5% YoY.
www.ri.rededor.com.br
www.ri.rededor.com.br
(1) Operational cash flow before interest payments.
5
CONSOLIDATED
- Net revenue sums R$51.3 billion in the year, 9.3% YoY growth.
- EBITDA totals R$8.5 billion in 2024, advancing 33.3% YoY. Consolidated EBITDA, summed the financial result of insurer's restricted assets, was R$9.5 billion, increase of 29.0% YoY.
- Net income reaches R$3.9 billion in the year, expansion of 81.6% vs. 2023.
- Adjusted net income approaches R$4.1 billion in 2024, excluding the accounting- only effect of the amortization of the value of the portfolios assumed in business combinations.
- Debt remains stable at 1.9x Net Debt/EBITDA at the end of the year, a drop of 0.4x vs. 2023.
- Operational cash flow(1) of R$9.8 billion generated in 2024, +71.2% YoY. In the year, R$1.45 billion was distributed in IoE, in addition to R$947 million invested in the Company's buyback programs.
Earnings Release 4Q24 | 5
INCOME STATEMENT
CONSOLIDATED
Managerial results do not consider IFRS 17 adoption. For reconciliation see report's annexes (pg. 34).
(R$ million) | RDOR | SULA | Eliminations(1) | 4Q24 | 4Q23 | Δ % | 2024 | ||
Gross revenue | 7,904.4 | 7,956.3 | (1,928.4) | 13,932.2 | 12,655.9 | 10.1% | 54,778.5 | ||
Hospitals, oncology and others | 7,904.4 | - | (1,928.4) | 5,976.0 | 5,630.7 | 6.1% | 24,458.5 | ||
Insurance and pension | - | 7,956.3 | - | 7,956.3 | 7,025.2 | 13.3% | 30,320.1 | ||
Deductions from gross revenue | (867.0) | (94.8) | 87.1 | (874.7) | (718.6) | 21.7% | (3,453.1) | ||
Glosses (disallowances) | (413.4) | - | 87.1 | (326.3) | (306.4) | 6.5% | (1,331.2) | ||
Taxes on revenue and others | (453.6) | (94.8) | - | (548.4) | (412.2) | 33.1% | (2,121.9) | ||
Net Revenue | 7,037.4 | 7,861.4 | (1,841.3) | 13,057.5 | 11,937.4 | 9.4% | 51,325.4 | ||
Hospitals, oncology and others | 7,037.4 | - | (1,841.3) | 5,196.1 | 4,968.7 | 4.6% | 21,302.1 | ||
Insurance and pension | - | 7,861.4 | - | 7,861.4 | 6,968.6 | 12.8% | 30,023.3 | ||
Changes in technical reserves | - | (218.8) | - | (218.8) | (195.9) | 11.7% | (774.0) | ||
Cost with hospitals services | (5,594.0) | - | - | (5,594.0) | (4,802.6) | 16.5% | (21,270.6) | ||
Personnel | (2,057.5) | - | - | (2,057.5) | (1,760.2) | 16.9% | (7,555.2) | ||
Materials and medicines | (1,554.7) | - | - | (1,554.7) | (1,378.7) | 12.8% | (6,060.1) | ||
Third-party services | (1,422.7) | - | - | (1,422.7) | (1,225.8) | 16.1% | (5,515.6) | ||
Utilities and services | (105.4) | - | - | (105.4) | (97.3) | 8.3% | (430.6) | ||
Rents | (26.3) | - | - | (26.3) | (23.1) | 14.2% | (102.5) | ||
Depreciation and amortization | (427.3) | - | - | (427.3) | (317.5) | 34.6% | (1,606.7) | ||
Operating costs | - | (6,698.6) | 1,841.3 | (4,857.3) | (4,958.5) | -2.0% | (19,694.3) | ||
Insurance | - | (6,585.6) | 1,841.3 | (4,744.3) | (4,838.5) | -1.9% | (19,179.3) | ||
Pension | - | (23.7) | - | (23.7) | (33.5) | -29.3% | (123.3) | ||
Other operating costs | - | (89.3) | - | (89.3) | (86.5) | 3.3% | (391.7) | ||
General and administrative expenses | (289.1) | (432.0) | - | (721.1) | (681.2) | 5.9% | (2,943.0) | ||
Personnel | (169.3) | (236.3) | - | (405.5) | (370.8) | 9.4% | (1,620.0) | ||
Third-party services | (48.5) | (92.3) | - | (140.8) | (129.5) | 8.8% | (526.5) | ||
Travel and accommodation | (19.5) | (2.3) | - | (21.8) | (17.8) | 23.0% | (78.8) | ||
Depreciation and amortization | (53.1) | (38.6) | - | (91.6) | (79.3) | 15.5% | (362.4) | ||
Provision of contingencies and others | 1.3 | (62.6) | - | (61.3) | (83.9) | -26.9% | (355.4) | ||
Selling expenses | (25.2) | (18.0) | - | (43.2) | (40.8) | 5.7% | (78.2) | ||
Equity pickup | 14.7 | 0.0 | - | 14.7 | (3.5) | -521.2% | 48.9 | ||
Other operating income/expenses | (91.9) | (69.1) | - | (161.0) | (166.3) | -3.2% | (104.2) | ||
Earnings before taxes and financial result | 1,052.0 | 424.9 | - | 1,477.0 | 1,088.4 | 35.7% | 6,509.9 | ||
EBITDA | 1,532.4 | 463.5 | - | 1,996.0 | 1,485.3 | 34.4% | 8,479.0 | ||
EBITDA margin (%) | 21.8% | 5.9% | - | 15.3% | 12.4% | 2,8 p.p. | 16.5% | ||
Adjusted EBITDA | 1,588.4 | 726.4 | - | 2,314.8 | 1,772.0 | 30.6% | 9,299.7 | ||
Adjusted EBITDA margin (%) | 22.6% | 9.2% | - | 17.7% | 14.8% | 2,9 p.p. | 18.1% | ||
(1) Includes eliminations and rebates between Group companies. | |||||||||
(R$ million) | Consolidated | 4Q24 | 4Q23 | Δ % | 2024 | ||||
Financial results | (478.2) | (339.0) | 41.1% | (1,641.1) | |||||
Financial revenues | 2,508.6 | 2,485.1 | 0.9% | 8,436.7 | |||||
Financial expenses | (2,986.8) | (2,824.2) | 5.8% | (10,077.8) | |||||
Earnings before taxes | 998.7 | 749.4 | 33.3% | 4,868.8 | |||||
Income Tax and Social Contribution | (119.2) | (81.3) | 46.7% | (933.0) | |||||
Current | (101.1) | (176.4) | -42.7% | (1,122.5) | |||||
Deferred | (18.2) | 95.1 | -119.1% | 189.5 | |||||
Net income | 879.5 | 668.1 | 31.6% | 3,935.8 | |||||
Net income attributed to controlling partners | 869.7 | 644.8 | 34.9% | 3,848.7 | |||||
Net income attributed to non-controlling partners | 9.8 | 23.3 | -58.1% | 87.2 | |||||
Adjusted net income | 932.1 | 720.7 | 29.3% | 4,146.3 | |||||
ROIC (LTM) | 25.9% |
Adjusted ROIC (LTM) | 16.8% |
16.6% | 9,2 p.p. |
17.2% | -0,4 p.p. |
www.ri.rededorwww.ri.rededor.com.br.com.br | Earnings Release 4Q24 | 6 |
www.ri.rededor.com.br |
INCOME STATEMENT
HOSPITALS, ONCOLOGY AND OTHERS
Managerial results do not consider IFRS 17 adoption. For reconciliation see report's annexes (pg. 34).
(R$ million) | 4Q24 | 4Q23 | Δ % | 3Q24 | Δ % | 2024 | 2023 | Δ % |
Gross revenue | 7,904.4 | 7,022.6 | 12.6% | 8,077.0 | -2.1% | 31,293.0 | 28,429.3 | 10.1% |
Hospitals and others | 7,074.7 | 6,307.1 | 12.2% | 7,253.8 | -2.5% | 28,095.6 | 25,692.9 | 9.4% |
Oncology (infusions) | 829.6 | 715.5 | 16.0% | 823.1 | 0.8% | 3,197.4 | 2,736.4 | 16.8% |
Deductions from gross revenue | (867.0) | (733.5) | 18.2% | (909.6) | -4.7% | (3,495.4) | (3,093.0) | 13.0% |
Glosses (disallowances) | (413.4) | (377.9) | 9.4% | (436.3) | -5.2% | (1,670.3) | (1,522.7) | 9.7% |
Taxes on revenue | (453.6) | (355.6) | 27.6% | (473.3) | -4.2% | (1,825.1) | (1,570.3) | 16.2% |
Net revenue | 7,037.4 | 6,289.1 | 11.9% | 7,167.4 | -1.8% | 27,797.6 | 25,336.2 | 9.7% |
Cost of services rendered | (5,594.0) | (4,802.6) | 16.5% | (5,442.0) | 2.8% | (21,270.6) | (19,356.3) | 9.9% |
Personnel | (2,057.5) | (1,760.2) | 16.9% | (1,918.3) | 7.3% | (7,555.2) | (6,806.6) | 11.0% |
Materials and medicines | (1,554.7) | (1,378.7) | 12.8% | (1,558.4) | -0.2% | (6,060.1) | (5,736.8) | 5.6% |
Third-party services | (1,422.7) | (1,225.8) | 16.1% | (1,436.4) | -1.0% | (5,515.6) | (4,808.0) | 14.7% |
Utilities and services | (105.4) | (97.3) | 8.3% | (104.3) | 1.0% | (430.6) | (403.3) | 6.8% |
Rents | (26.3) | (23.1) | 14.2% | (25.3) | 4.0% | (102.5) | (91.0) | 12.6% |
Depreciation and amortization | (427.3) | (317.5) | 34.6% | (399.3) | 7.0% | (1,606.7) | (1,510.6) | 6.4% |
General and administrative expenses | (289.1) | (261.3) | 10.6% | (306.0) | -5.5% | (1,145.7) | (735.2) | 55.8% |
Personnel | (169.3) | (176.4) | -4.0% | (203.3) | -16.8% | (762.6) | (694.4) | 9.8% |
Third-party services | (48.5) | (36.4) | 33.4% | (33.1) | 46.6% | (171.0) | (141.8) | 20.6% |
Travel and accommodation | (19.5) | (15.6) | 25.7% | (17.3) | 12.9% | (70.5) | (63.5) | 11.0% |
Depreciation and amortization | (53.1) | (30.4) | 74.4% | (52.0) | 1.9% | (206.9) | (165.0) | 25.4% |
Provision of contingencies and others | 1.3 | (2.6) | n.a. | (0.2) | n.a. | 65.2 | 329.4 | -80.2% |
Selling expenses | (25.2) | (19.2) | 30.8% | (0.0) | n.a. | (37.3) | (167.2) | -77.7% |
Equity pickup | 14.7 | (7.6) | n.a. | 20.0 | -26.3% | 27.5 | (10.0) | n.a. |
Other operating income/expenses | (91.9) | (121.6) | -24.4% | 249.1 | n.a. | (16.8) | (396.8) | -95.8% |
Earnings before taxes and financial result | 1,052.0 | 1,076.8 | -2.3% | 1,688.4 | -37.7% | 5,354.5 | 4,670.8 | 14.6% |
EBITDA | 1,532.4 | 1,424.7 | 7.6% | 2,139.8 | -28.4% | 7,168.1 | 6,346.4 | 12.9% |
EBITDA margin (%) | 21.8% | 22.7% | -0,9 p.p. | 29.9% | -8,1 p.p. | 25.8% | 25.0% | 0,7 p.p. |
Adjusted EBITDA | 1,588.4 | 1,470.3 | 8.0% | 1,834.1 | -13.4% | 6,999.8 | 6,360.9 | 10.0% |
Adjusted EBITDA margin (%) | 22.6% | 23.4% | -0,8 p.p. | 25.6% | -3 p.p. | 25.2% | 25.1% | 0,1 p.p. |
www.ri.rededorwww.ri.rededor.com.br.com.br | Earnings Release 4Q24 | 7 |
www.ri.rededor.com.br |
INCOME STATEMENT
INSURANCE, PENSION & ASSET MANAGEMENT
Managerial results do not consider IFRS 17 adoption. For reconciliation see report's annexes (pg. 34).
(R$ million) | 4Q24 | 4Q23 | Δ % | 3Q24 | Δ % | 2024 | 2023 | Δ % |
Net Revenue | 7,861.4 | 6,974.1 | 12.7% | 7,630.4 | 3.0% | 30,023.3 | 26,966.6 | 11.3% |
Insurance revenues (excl. intercompany eliminations) | 7,536.4 | 6,703.4 | 12.4% | 7,367.7 | 2.3% | 28,923.8 | 26,052.7 | 11.0% |
Pension revenues | 264.2 | 238.0 | 11.0% | 204.0 | 29.5% | 863.8 | 796.7 | 8.4% |
Other health plans and insurance revenues | 60.8 | 32.8 | 85.4% | 58.8 | 3.5% | 235.6 | 117.2 | 101.0% |
Changes in technical reserves | (218.8) | (195.9) | 11.7% | (181.8) | 20.3% | (774.0) | (694.1) | 11.5% |
Insurance | 5.9 | 6.3 | -5.0% | (20.2) | -129.4% | (71.1) | (59.1) | 20.3% |
Pension | (224.7) | (202.2) | 11.1% | (161.6) | 39.1% | (702.9) | (635.0) | 10.7% |
Operating Costs | (6,698.6) | (6,284.4) | 6.6% | (6,656.8) | 0.6% | (26,189.7) (24,765.0) | 5.8% | |
Insurance | (6,585.6) | (6,164.4) | 6.8% | (6,527.1) | 0.9% | (25,674.8) | (24,250.4) | 5.9% |
Claims (excl. intercompany eliminations) | (6,094.1) | (5,742.5) | 6.1% | (6,065.3) | 0.5% | (23,821.6) | (22,529.9) | 5.7% |
Acquisition costs | (491.5) | (421.9) | 16.5% | (461.9) | 6.4% | (1,853.1) | (1,720.6) | 7.7% |
Pension | (23.7) | (33.5) | -29.3% | (37.6) | -37.1% | (123.3) | (131.5) | -6.2% |
Other operating costs | (89.3) | (86.5) | 3.3% | (92.1) | -3.0% | (391.7) | (383.1) | 2.2% |
General and administrative expenses | (432.0) | (419.9) | 2.9% | (446.1) | -3.2% | (1,797.3) | (1,518.8) | 18.3% |
Personnel | (236.3) | (194.4) | 21.5% | (198.2) | 19.2% | (857.4) | (786.4) | 9.0% |
Third-party services | (92.3) | (93.1) | -0.8% | (84.5) | 9.2% | (355.5) | (317.9) | 11.8% |
Travel and accommodation | (2.3) | (2.2) | 4.2% | (2.0) | 17.0% | (8.3) | (6.9) | 20.7% |
Depreciation and amortization | (38.6) | (48.9) | -21.1% | (39.8) | -3.2% | (155.5) | (193.0) | -19.5% |
Provision of contingencies and others | (62.6) | (81.3) | -23.0% | (121.6) | -48.5% | (420.6) | (214.5) | 96.0% |
Selling expenses | (18.0) | (21.6) | -16.6% | (5.5) | 228.6% | (40.9) | (46.7) | -12.4% |
Equity pickup | - | 4.1 | n.a. | (0.0) | n.a. | 21.4 | 4.3 | 399.6% |
Other operating expenses | (69.1) | (44.7) | 54.4% | (22.2) | 211.1% | (87.4) | (126.4) | -30.9% |
Earnings before taxes and financial results | 424.9 | 11.6 | n.a. | 318.0 | 33.6% | 1,155.4 | (180.1) | n.d. |
EBITDA | 463.5 | 60.5 | 665.5% | 357.9 | 29.5% | 1,310.9 | 12.9 | n.d. |
(+) Financial results over restricted assets | 262.9 | 241.2 | 9.0% | 251.6 | 4.5% | 989.0 | 940.2 | 5.2% |
(+) Non-recurring expenses (Rede D'Or integration) | - | 0.0 | n.a. | - | n.a. | - | 40.3 | n.d. |
Adjusted EBITDA | 726.4 | 301.7 | 140.8% | 609.5 | 19.2% | 2,299.9 | 993.4 | 131.5% |
www.ri.rededorwww.ri.rededor.com.br.com.br | Earnings Release 4Q24 | 8 |
www.ri.rededor.com.br |
ENVIRONMENTAL, SOCIAL & GOVERNANCE
Aiming to minimize the impacts of operations and build a positive and transparent relationship with society, Rede D'Or is committed to a series of Environmental, Social and Governance (ESG) initiatives, including those of the principles of the UN
Global Compact and the 2030 Agenda.
Of the 17 Sustainable Development Goals (SDGs) that make up the UN program, the Company is committed to contributing to the achievement of eight priority SDGs, namely:
good health and well-being (SDG 3); quality education (SDG 4); gender equality (SDG 5); decent work and economic growth (SDG 8); industry, innovation and infrastructure (SDG 9); responsible consumption and production (SDG 12); climate action (SDG 13); e peace, justice and strong institutions
(SDG 16).
In this section, you will find the main Rede
D'Or Sustainability initiatives, segmented in
the ESG topics.
SDG D'OR PROGRAM | GOALS
Good health and well-being: Achieve zone of quality NPS in hospital performance (except Star hospitals) by 2030.
Gender equality: ensure that at least 50% of leadership positions (supervision, coordination, management and senior management) are held by women by December 2025.
Decent work and economic growth:
Restructure and launch the Diversity and Inclusion program by December 2024.
Industry, innovation and infrastructure:
Adopt hydraulic system equipment with low water consumption in at least 90% of specifications in each project completed annually.
Responsible consumption and
production: Reach 30% recyclable waste rate by 2030.
Climate action: Reduce by 36% greenhouse gas emissions (GHG) by intensity through 2030.
Peace, justice and strong institutions:
Train 90% of active employees and contractors (those holding leadership positions in the hospital units) on integrity- related procedures by 2025.
www.ri.rededorwww.ri.rededor.com.br.com.br | Earnings Release 4Q24 | 9 |
www.ri.rededor.com.br |
ENVIRONMENTAL, SOCIAL & GOVERNANCE
ENVIRONMENTAL
Emissions. Since 2016, the Company has adopted the methodology of the Brazilian GHG Protocol Program, to measure GHG emissions. In the last cycle, Rede D'Or presented certified inventories for 133 business units. The 2024 cycle will be completed in mid-2025.
TARGET: Reduce by 36% its greenhouse gas emissions by intensity through 2030 and zero emissions by 2050, in line with our Race to Zero commitment.
Energy efficiency. Rede D'Or bases construction for new units, adaptations, or renovations of acquired hospitals on sustainable premises. This includes, for example, energy efficiency linked to the building envelope, prioritization for more modern and efficient equipment, use of compact high energy efficiency fluorescent lamps or high-performance tubular lamps, and use of air-cooling technologies that allow the automation of the system in order to enable the appropriate sectorization of the air-conditioned environments. In 2024, the company had 24 Energy Efficiency project contracts at the chilled water center (CAG) in operation, that generated a 17% reduction in energy consumption.
TARGET: Maintain in at least 10% the annual reduction in electricity consumption of all units adhering to the water efficiency project by 2024.
Waste management. In 2024, the Company generated 37,615 kilos of waste, representing an increase of approximately 5% compared to 2023, a relevant challenge
due to the increase in the number of beds in the year.
TARGET: Reach 30% recyclable waste rate by 2030.
HIGHLIGHTS
Rede D'Or plans to reach a total of 74 consumer units operating in the Free Energy Market (MLE) with energy from renewable sources by 2025.
In December 2024, the Company had 75 consumer units (allocated in 70 hospitals and clinics) operating in the MLE.
Carbon Disclosure Project (CDP)
Rede D'Or was awarded a score of C in the CDP Climate Change section and score B- in its second report to the water security questionnaire. CDP Climate is a benchmark in the evaluation of sustainable actions that contribute to the battle against climate change, and the analysis is also used as an entry criterion and to evaluate companies by the Corporate Sustainability Index (ISE B3).
Sustainability Indexes
For the third consecutive year, Rede D'Or was part of the Carbon Efficient Index (ICO2) from B3.
www.ri.rededorwww.ri.rededor.com.br.com.br | Earnings Release 4Q24 | 10 |
www.ri.rededor.com.br |